Analytical Data
-
Gene name
SCT
- Application
-
Alternative Names
SCT；Secretin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09683
-
Expression Region
28-54aa
-
AA Sequence
HSD GTFTSELSRL REGARLQRLL QGLV
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCT (Suprachiasmatic nucleus Circadian Timing) recombinant proteins have garnered increasing attention in the field of circadian biology due to their crucial role in regulating circadian rhythms in mammals. The suprachiasmatic nucleus (SCN) in the hypothalamus is known as the body's master clock, orchestrating various physiological processes through a network of molecular and cellular mechanisms. The disruption of these circadian rhythms has been linked to various health issues, including sleep disorders, metabolic syndrome, and mood disorders. As researchers delve deeper into circadian signaling pathways, SCT recombinant proteins have emerged as vital tools for elucidating the mechanisms underlying circadian regulation. These proteins, produced through genetic engineering techniques, can be used to study the interactions between circadian genes and proteins, offering insights into how these factors influence behavior and physiology. By exploring the structural and functional characteristics of SCT proteins, scientists aim to better understand their role in maintaining circadian homeostasis and developing targeted therapies for circadian-related disorders. Furthermore, the application of SCT recombinant proteins in experimental models can lead to breakthroughs in chronotherapy, where timing is optimized for drug administration, enhancing therapeutic efficacy while minimizing side effects. Overall, the research on SCT recombinant proteins is paving the way for significant advancements in our understanding of circadian biology and its implications for health and disease.
